巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02367 巨子生物

已收盘 06-01 16:08:27

29.480

+0.809

+2.82%

最高29.560	最低27.900	成交量755.67万
今开28.500	昨收28.671	日振幅5.79%
总市值313.08亿	流通市值313.08亿	总股本10.62亿
成交额2.19亿	换手率0.71%	流通股本10.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":29.48,"timestamp":1780301307003,"preClose":28.671,"halted":0,"volume":7556661,"delay":0,"changeRate":0.028216664922744272,"floatShares":1061999999,"shares":1061999999,"eps":2.097000745809202,"marketStatus":"已收盘","change":0.809,"latestTime":"06-01 16:08:27","open":28.5,"high":29.56,"low":27.9,"amount":218750756,"amplitude":0.057898,"askPrice":29.48,"askSize":600,"bidPrice":29.44,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":2.097000745809202,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780363800000},"marketStatusCode":5,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":28.671,"dividendRate":0.021005,"openAndCloseTimeList":[[1780277400000,1780286400000],[1780290000000,1780300800000]],"volumeRatio":0.992043,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367/tweets","defaultTab":"tweets","newsList":[{"id":"2640939935","title":"港股异动 | 部分美妆股涨幅扩大 毛戈平(01318)尾盘涨超10% 机构指国货品牌预计在618后半段崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2640939935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640939935?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:27","pubTimestamp":1780298834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，部分美妆股涨幅扩大，截至发稿，毛戈平涨9.69%，报65.65港元；上美股份涨6.16%，报38.6港元；巨子生物涨2.75%，报29.46港元。天猫方面，李佳琦预计在618后半段将加播美妆产品，助力合作品牌销售。华源证券则表示，化妆品首次纳入地方消费补贴范围，从化妆品补贴力度来看，补贴力度或进一步向头部优质美妆品牌倾斜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01318","LU2488822045.USD","02145","02367","LU0455707207.USD","LU0348767384.USD","LU0348766576.USD","VXUS","LU0502904849.HKD","BK4588","SG9999004311.SGD","BK1207","BK4585","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143161668","title":"异动解读｜巨子生物盘中上涨5.33%，股东大会通过高额派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1143161668","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143161668?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:25","pubTimestamp":1780025150,"startTime":"0","endTime":"0","summary":"5月29日，巨子生物盘中上涨5.33%，报28.46港元，成交额7634.88万港元。消息面上，公司于5月28日召开股东周年大会，全票通过末期股息及特别股息方案，合计每股派发人民币1.2104元，其中末期股息每股0.539元、特别股息每股0.6714元，将于6月25日派发，除净日为6月1日。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648884","title":"【券商聚焦】中信建投：美妆行业迈入高质量发展阶段 本土品牌开启提质进阶之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648884","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639648884?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:15","pubTimestamp":1780017310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指出，国内美妆行业正式迈入高质量发展阶段，2025年市场规模达8225亿元，同比增长6.18%，行业需求韧性凸显。行业供给端持续重塑，新规落地推动行业合规化升级，市场出清持续。当前美妆品牌集中度已对标海外成熟市场，但集团化整合仍存较大空间。同时行业仍面临宏观消费波动、监管趋严、流量成本攀升及爆款迭代过快等多重风险。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982469","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02145","BK1207","LU2488822045.USD","LU0455707207.USD","LU0502904849.HKD","LU2242644610.SGD","SG9999004311.SGD","BK0276","02367","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123292614","title":"巨子生物更新末期股息：每股派0.6187港元，6月25日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1123292614","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123292614?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:22","pubTimestamp":1779974555,"startTime":"0","endTime":"0","summary":"巨子生物(02367)发布更新公告，明确了截至2025年12月31日止年度的末期股息派发细节。此次调整主要涉及派息金额及公司预设派发货币。\n公司宣派的普通末期股息为每股人民币0.539元，预设以港元派付。按照1人民币兑1.1479港元的汇率折算，每股股息为0.6187港元。股权登记日为2026年6月8日，股东须在6月2日16:30前完成股份过户文件递交，方可享有该股息。股份将自6月3日至6月8日暂停办理过户登记，除净日定为6月1日。股息最终将于2026年6月25日派发。\n公告显示，此次股息不涉及代扣所得税。该末期股息方案已于2026年5月28日获股东批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"巨子生物更新末期股息：每股派0.6187港元，6月25日派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131889327","title":"巨子生物宣派末期及特别股息，每股合计1.2104元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1131889327","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131889327?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:21","pubTimestamp":1779974519,"startTime":"0","endTime":"0","summary":"巨子生物于2026年5月28日举行股东周年大会，表决并通过了包括股息分派在内的全部决议案。董事会随后宣布，将向股东派发截至2025年12月31日止年度的末期股息每股人民币0.5390元及特别股息每股人民币0.6714元，合计每股派发人民币1.2104元。以中国人民银行于股东大会当日公布的人民币兑港元汇率中间价计算，末期股息折合约每股0.6187港元，特别股息折合约每股0.7707港元。此次股息方案获股东大会全票通过，末期股息及特别股息相关决议案均获得100%赞成票。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"巨子生物宣派末期及特别股息，每股合计1.2104元人民币","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149695407","title":"巨子生物宣派特别股息每股0.6714元，6月25日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1149695407","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149695407?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:21","pubTimestamp":1779974513,"startTime":"0","endTime":"0","summary":"巨子生物(02367)最新公告显示，公司已更新截至2025年12月31日止年度的特别股息方案，宣派每股0.6714元人民币（或每股0.7707港元）的特别股息。\n此次特别股息已于2026年5月28日获股东批准。按预设货币计算，股息将以每股0.7707港元派发，所用汇率为1元人民币兑1.1479港元。除净日定于6月1日，递交股份过户文件的最后时限为6月2日下午4时30分，公司将于6月3日至6月8日暂停办理股份过户登记，权益登记日为6月8日。股息派发日则为6月25日，股份过户登记处为卓佳证券登记有限公司。公告未涉及代扣所得税安排。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"巨子生物宣派特别股息每股0.6714元，6月25日派发","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638169650","title":"巨子生物(02367)将于6月25日派发末期股息每股0.539元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638169650","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638169650?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:13","pubTimestamp":1779973988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物(02367)发布公告，该公司将于2026年6月25日派发末期股息每股0.539元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02367","BK1207","BK4585","LU2488822045.USD","VIG","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637587411","title":"618前哨战：胶原蛋白产品进入货架淘汰赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2637587411","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637587411?lang=zh_cn&edition=full","pubTime":"2026-05-21 08:06","pubTimestamp":1779321960,"startTime":"0","endTime":"0","summary":"【618前哨战：胶原蛋白产品进入货架淘汰赛】今年618大促陆续启动，各大胶原品牌也提前站上美妆护肤货架的中心位置。在各大主播直播间预告中，锦波生物合作品牌“同频”次抛精华、巨子生物旗下可复美胶原棒2.0、丸美生物旗下胶原小金针精华等胶原产品，相继公布活动优惠机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605213743982054.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605213743982054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687104","title":"【券商聚焦】中国银河：医药行业进入复苏周期 CXO板块景气度较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633687104?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:00","pubTimestamp":1778202049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券表示，2025年医药行业上市公司营业收入增长0.4%，归母净利润增长3.9%，扣非净利润下降4.1%，2026年一季度营业收入增长1.1%，归母净利润下降3.2%，扣非净利润增长2.0%。2025全年医药行业收入端小幅微增，主要系医保控费趋严，仿制药、耗材等集采常态化开展导致行业承压。2026年一季度创新药产业链高景气度延续，收入增幅扩大、非经常性损益占比下降，行业整体经营盈利能力提升，进入复苏上行周期。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06881","LU0307460666.USD","02196","06821","LU0588546209.SGD","BK1197","BK1161","HK0000165453.HKD","01099","09688","LU0348735423.USD","LU1719994722.HKD","IE00BPRC5H50.USD","02268","601881","BK1588","01789","LU2476274720.SGD","01530","CXO","BK1593","LU0634319403.HKD","LU0348783233.USD","09926","LU1969619763.USD","LU2488822045.USD","LU1303224171.USD","LU2328871848.SGD","LU2778985437.USD","BK1141","LU0348767384.USD","02367","LU1794554557.SGD","LU0561508036.HKD","03933","BK1585","02228","06160","LU0640798160.USD","LU0417516902.SGD","BK0188","BK0276","LU0417516571.SGD","BK1207","LU0348766576.USD","BK1500","BK1583","LU1251922891.USD","LU1961090484.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633101233","title":"【券商聚焦】华泰证券：美容护理板块处于“三低”状态 建议积极跟踪618/新品势能等催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2633101233","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633101233?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:58","pubTimestamp":1778201918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，美容护理板块现处于预期低/估值低/持仓低的“三低”状态，行业面/资金面/基本面等维度的边际改善均有可能带来积极变化。从财报情况来看，部分标的业绩改善迹象已现，复苏节奏和斜率略有差异。整体而言品牌商及医美上游厂商分化明显，代工厂逐步复苏，代运营商转型持续兑现。建议积极跟踪618/新品势能等催化剂，若个股有盈利预测上修潜力，戴维斯双击或可期待。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601688","LU0502904849.HKD","LU1808992512.USD","LU1979443071.USD","BK1593","01830","02367","BK1207","LU1328615791.USD","BK0276","LU0164865239.USD","LU1580142542.USD","BK0183","LU2488822045.USD","LU1064131003.USD","LU2148510915.USD","LU0871576103.HKD","BK0012","02145","LU0531971595.HKD","LU2242644610.SGD","BK1215","SG9999004311.SGD","BK0028","LU1064130708.USD","LU0455707207.USD","BK0188","LU0039217434.USD","LU1781817850.SGD","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170257438","title":"巨子生物授予董事股份回购授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1170257438","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170257438?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:40","pubTimestamp":1778074851,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于最新公告中披露，将在2026年5月28日召开的股东周年大会上提呈普通决议案，拟向董事会授予回购公司股份的一般性授权，规模最高可达截至股东周年大会当日公司已发行股份总数的10%。该授权若获通过，董事会最多可在香港联交所回购约106,170,400股股份。据公告，股东大会将于2026年5月28日在中国陕西省西安市长安区上林苑七路1855号召开。董事会认为，该计划有助优化公司资本结构和提升股东整体回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"巨子生物授予董事股份回购授权，规模达已发行股本一成","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1137592575","title":"巨子生物4月股份变动月报：本月购回并注销920万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1137592575","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137592575?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:40","pubTimestamp":1778074845,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于2026年5月6日发布2026年4月股份变动月报表，披露了公司在2026年4月的股本及股份变动情况。截至2026年4月30日，公司法定注册股本为5,000,000,000股，面值每股0.00001美元，注册股本金额50,000美元。公司于2026年4月20日依据2025年6月13日股东大会决议进行了股份购回，并已将上述购回的股份予以注销，本月末未持有任何库藏股。截至4月30日，公司已发行股份共1,061,704,000股，仍满足香港联交所要求的最低公众持股比例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2632589698","title":"可复美再推“大单品” 巨子生物想寻找修复新支点","url":"https://stock-news.laohu8.com/highlight/detail?id=2632589698","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632589698?lang=zh_cn&edition=full","pubTime":"2026-05-01 07:00","pubTimestamp":1777590000,"startTime":"0","endTime":"0","summary":"经历2025年业绩承压后，巨子生物（02367.HK）正在迎来一个新的观察窗口。4月中旬以来，该公司旗下可复美新单品“超透棒”在多个电商平台密集铺开。公开信息显示，该产品上市前后，可复美在微博、抖音、京东等渠道连续预热，并通过明星、达人内容及自营渠道形成新品声量。多家券商渠道跟踪信息显示，可复美超透棒上市后销售爬坡较快。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605013726851714.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605013726851714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631327756","title":"巨子生物(02367.HK)拟委任毕马威为公司新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2631327756","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631327756?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:27","pubTimestamp":1777552022,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨巨子生物(02367.HK)公告，于2026年4月30日，董事会已议决：(1)不再重新委任公司现任核数师安永，因此安永将于应届股东周年大会结束时退任公司核数师；及(2)经公司审核委员会建议，建议委任毕马威为公司新核数师。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260430/32195059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186056667","title":"巨子生物2025年营收微幅下滑，专业皮肤护理业务保持领先","url":"https://stock-news.laohu8.com/highlight/detail?id=1186056667","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186056667?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:16","pubTimestamp":1777464967,"startTime":"0","endTime":"0","summary":"巨子生物在截至2025年12月31日止年度实现收入人民币55.19亿元，较上年同期微降0.4%；年内利润为人民币19.15亿元，同比下降7.1%。公司毛利约为人民币44.33亿元，毛利率由上年度的82.1%降至约80.3%，主要受部分产品短期销售承压及成本结构调整影响。研发投入为人民币0.89亿元，在攻关重组蛋白、透明质酸等前沿领域的同时，进一步增强了科研储备与创新能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"巨子生物2025年营收微幅下滑，专业皮肤护理业务保持领先","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630566302","title":"医美上市企业2025年业绩集体承压！爱美客、昊海生科、巨子生物等营收、净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2630566302","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630566302?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:24","pubTimestamp":1777379070,"startTime":"0","endTime":"0","summary":"红星资本局4月28日消息，近日，多家医美上市企业陆续交出2025年的“成绩单”。红星资本局注意到，多家龙头医美企业踩下业绩高增长的“急刹车”，出现营收、净利双降的情况；也有企业困于单一品牌，给业绩增长带来难题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283722723751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688366","IPOS","300896","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630329652","title":"功能性护肤股2025财报全降，药妆故事为何集体失速？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630329652","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630329652?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:49","pubTimestamp":1777351749,"startTime":"0","endTime":"0","summary":"曾被资本追逐、被消费者追捧的功能性护肤赛道突然集体“失速”。2025年财报季披露已近尾声，回溯曾经风光无限的功能性护肤赛道，一个颇为沉重的信号浮出水面。热门“药妆”概念股集体交出下滑成绩单，行业高歌猛进的时代已告一段落。六家代表性上市公司无一幸免，但下滑的幅度与性质截然不同。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721978987.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721978987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629048015","title":"【券商聚焦】华泰研究维持巨子生物(02367)“买入”评级 看好新品销售及医美进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2629048015","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629048015?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:39","pubTimestamp":1776847155,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰研究发布研报指，巨子生物 核心看点在于新品推出带来的销售改善以及医美业务取得实质性进展，预期公司将于2026年重回增长轨道。该行维持对巨子生物的“买入”评级及目标价45港元。研报认为，可复美品牌自2025年6月起进入低基数阶段，新品的市场表现及其胶原系列、焦点系列等现有产品的销售节奏值得持续跟踪。盈利预测方面，华泰研究维持对巨子生物2026年至2028年的归母净利润预测，分别为19.33亿元、21.27亿元及23.02亿元人民币。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979650","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629090949","title":"国货美妆品牌抢占线下折扣店","url":"https://stock-news.laohu8.com/highlight/detail?id=2629090949","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629090949?lang=zh_cn&edition=full","pubTime":"2026-04-22 15:24","pubTimestamp":1776842640,"startTime":"0","endTime":"0","summary":"国货美妆品牌抢占线下折扣店","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604223713962495.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604223713962495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603605","LU1820825898.SGD","300957","LU0593848301.USD","BK0229","688363","BK0196","BK0273","BK0012","LU1997245094.SGD","301371","BK0070","BK0239","600315","LU0274383008.USD","LU2488822045.USD","IE0005HP3H50.USD","BK0028","02367","600223","LU1146622755.USD","SG9999004311.SGD","LU2460026573.USD","BK0188","BK1207","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629703720","title":"港股异动 | 巨子生物(02367)再涨超7% 央视深度探厂巨子生物 机构看好公司新产品及新业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2629703720","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629703720?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:58","pubTimestamp":1776736706,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物再涨超7%，截至发稿，涨5.8%，报31.38港元，成交额1.89亿港元。考虑到公司两款三类医疗器械“重组 I 型α1 亚型胶原蛋白冻干纤维”、“重组 I 型α1 亚型胶原蛋白及透明质酸钠复合溶液产品”陆续获批，展现其持续领先的创新能力及战略定力。后续两款医美产品的陆续商业化、以及多款妆类新品的上市值得期待，建议持续关注公司新产品和新业务进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","LU2488822045.USD","VXUS","BK4588","BK4585","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":0.0955},{"period":"1month","weight":0.0094},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.1692},{"period":"1year","weight":-0.5481},{"period":"ytd","weight":-0.0968}],"compareEarnings":[{"period":"1week","weight":-0.0165},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0544},{"period":"6month","weight":-0.0262},{"period":"1year","weight":0.0683},{"period":"ytd","weight":-0.0175}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家主要从事基于生物活性成分的美丽与健康产品的研发、制造及销售业务的投资控股公司。该公司的主要产品包括功效性护肤品、医用敷料等专业皮肤护理产品，以及保健食品及其他产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.063759},{"month":2,"riseRate":0.75,"avgChangeRate":0.082298},{"month":3,"riseRate":0.75,"avgChangeRate":0.049732},{"month":4,"riseRate":0.75,"avgChangeRate":0.023751},{"month":5,"riseRate":0.25,"avgChangeRate":-0.038836},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.053764},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.046799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.018731},{"month":9,"riseRate":0.666667,"avgChangeRate":0.061782},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.126143},{"month":11,"riseRate":0.333333,"avgChangeRate":0.019827},{"month":12,"riseRate":0.25,"avgChangeRate":0.047101}],"exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}